January 30, 2019
Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients
Read More
January 30, 2019
Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients
Read More
January 30, 2019
A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
Read More
January 30, 2019
A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4
Read More
January 30, 2019
Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C
Read More
January 30, 2019
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
Read More
January 30, 2019
An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection
Read More
X